Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesHigh-dose fluticasone in preschool viral wheezing: what is the real advantage
Breathe, 06/09/09
Pre-emptive administration of high-dose fluticasone at the onset of URI reduced the frequency of clinician-initiated treatment with OC by 10 percentage points, with a relative reduction of 50%. In the FG, children received fewer days of albuterol, parents’ quality of life improved and symptoms were milder and shorter. However, use of pre-emptive high-dose fluticasone was associated with a reduced gain in height and weight; consequently the potential risks outweighed the identifi ed benefits.
Related Articles
Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo
Clinical and Experimental Allergy, 11/20/09
Relevance Score: 80%
Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall
Journal of Allergy and Clinical Immunology, 11/19/09
Relevance Score: 80%
Beta2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate
American Journal of Respiratory and Critical Care Medicine, 11/17/09
Relevance Score: 80%
Adherence to Combined Montelukast and Fluticasone Treatment in Economically Disadvantaged African American Youth with Asthma
Journal of Asthma, 11/13/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sedation during Flexible Bronchoscopy in Patients with Pre-Existing Respiratory Failure: Midazolam versus Midazolam plus Alfentanil
Respiration, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Today in Pediatric Pulmonology...keeping you current
Receive free subspecialty "5-minute updates" via email
Serologically verified human bocavirus pneumonia in children
Pediatric Pulmonology, 12/18/09
Modifiable Risk Factors for Asthma Morbidity in Bronx Versus Other Inner-City Children
Journal of Asthma, 12/17/09
Predicting short term response to anti-inflammatory therapy in young children with asthma
Current Medical Research and Opinion, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor